Patent ID: 9592407
Date: 2017-03-14
CPC Classifications: A61K,A61N,A61P,C12N

Claim:
1. A method for reducing or inhibiting cancer cells in a subject, the method comprising the steps of: (a) contacting the cancer cells with an NPM inhibitor, wherein the NPM inhibitor is gambogic acid; and (b) administering an effective amount of an anti-cancer agent, wherein the anti-cancer agent is target cancer therapy, wherein said target cancer therapy is “sorefenib or lapatinib”; wherein the cancer cells are selected from the group consisting of hepatocarcinoma, gastric cancer, cholangiocarcinoma, colorectal cancer, ovarian cancer, lung cancer, uterine cancer, and breast cancer, wherein said steps of contacting and administering provide a synergistic effect on reducing or inhibiting said cancer cells in said subject.